Myopia of Prematurity: Reduced Progression Using Highly Aspherical Lenslet Target (HALT) Technology

Raffaele Parrozzani1, Carolina Molin1, Alessandro Carli1

  • 1Department of Neuroscience-Ophthalmology, University of Padova, 35128 Padova, Italy.

PubMed

Insights

Highly Aspherical Lenslet Target (HALT) technology may slow myopia progression in premature infants. This study found HALT lenses reduced myopia of prematurity (MOP) progression compared to standard lenses, potentially lowering long-term visual impairment risks.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Myopia Research

Background:

  • Myopia of prematurity (MOP) is a distinct refractive error in premature infants, distinct from school-age myopia.
  • MOP increases the risk of high myopia and lifelong complications.
  • Retinopathy of prematurity (ROP) is a common complication in premature infants that can be associated with MOP.

Purpose of the Study:

  • To evaluate the efficacy of Highly Aspherical Lenslet Target (HALT) technology in managing MOP progression.
  • To compare MOP progression in children using HALT lenses versus conventional single-vision lenses.
  • To assess the impact of HALT lenses on spherical equivalent (SE) and axial length (AL) in children with MOP.

Main Methods:

  • A comparative study involving 58 preterm children diagnosed with MOP.
  • Two groups were formed: one using HALT lenses and the other using standard single-vision lenses for 12 months.
  • Spherical equivalent (SE) and axial length (AL) were measured to track myopia progression.

Main Results:

  • Children using HALT lenses showed significantly lower SE progression (-0.32 D) and AL elongation (0.12 mm) compared to the standard lens group (-0.93 D and 0.46 mm, p < 0.0001) at 12 months.
  • The HALT group demonstrated a marked reduction in myopia progression indicators.
  • A statistically significant difference (p < 0.0001) was observed between the two groups.

Conclusions:

  • HALT lens technology appears to reduce the progression of myopia of prematurity (MOP).
  • These findings suggest HALT lenses may be a beneficial intervention for high-risk pediatric myopia.
  • Further research into HALT technology for specific high-risk subgroups is warranted to mitigate severe myopia and visual impairment risks.

Related Concept Videos

Reducing Line Loss01:18

Reducing Line Loss

In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
385
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.6K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.4K